USFDA clears Dr Reddy’s licence application for biosimilar to Orencia

Dr. Reddy's receives USFDA approval for a biosimilar to Orencia, targeting arthritis treatment with a cost-effective infusion option.

You will be redirected in 10 seconds.

liveinternet liveinternet